We are live on ! Find out more
RRCM

Rappaport Reiches Capital Management Portfolio holdings

AUM $400M
1-Year Est. Return 7.92%
This Fund
S&P 500
This Quarter Est. Return
+0.09%
1 Year Est. Return
+7.92%
3 Year Est. Return
+17.58%
5 Year Est. Return
10 Year Est. Return
AUM
$387M
AUM Growth
+$11.1M
Cap. Flow
+$12.3M
Cap. Flow %
3.18%
Top 10 Hldgs %
71.69%
Holding
116
New
3
Increased
54
Reduced
30
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 11.97%
2 Financials 3.17%
3 Communication Services 2.3%
4 Consumer Discretionary 1.4%
5 Healthcare 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUBS icon
76
HubSpot
HUBS
$10.5B
$328K 0.08%
471
+11
+2% +$7.07K
IBM icon
77
IBM
IBM
$222B
$312K 0.08%
1,418
-84
-6% -$18.7K
VXUS icon
78
Vanguard Total International Stock ETF
VXUS
$164B
$307K 0.08%
5,218
-1,543
-23% -$95.6K
SDY icon
79
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$298K 0.08%
2,259
TSM icon
80
TSMC
TSM
$2.23T
$292K 0.08%
1,477
-22
-1% -$4.26K
SLYG icon
81
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.22B
$291K 0.08%
3,223
TMO icon
82
Thermo Fisher Scientific
TMO
$223B
$288K 0.07%
554
-2
-0.4% -$1.1K
HEWJ icon
83
iShares Currency Hedged MSCI Japan ETF
HEWJ
$763M
$282K 0.07%
6,625
+699
+12% +$29.5K
DGRW icon
84
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
$274K 0.07%
3,391
JPM icon
85
JPMorgan Chase
JPM
$971B
$256K 0.07%
1,068
+39
+4% +$9.08K
ASML icon
86
ASML
ASML
$695B
$254K 0.07%
366
+2
+0.5% +$1.44K
FISV
87
Fiserv Inc
FISV
$27.4B
$252K 0.07%
1,227
V icon
88
Visa
V
$671B
$249K 0.06%
789
+10
+1% +$3.01K
SRE icon
89
Sempra
SRE
$56.2B
$247K 0.06%
2,820
+6
+0.2% +$525
MTUM icon
90
iShares MSCI USA Momentum Factor ETF
MTUM
$26B
$244K 0.06%
1,179
C icon
91
Citigroup
C
$231B
$238K 0.06%
3,374
+48
+1% +$3.23K
PEP icon
92
PepsiCo
PEP
$189B
$235K 0.06%
1,544
+2
+0.1% +$328
SO icon
93
Southern Company
SO
$106B
$234K 0.06%
2,847
+3
+0.1% +$263
PHYS icon
94
Sprott Physical Gold
PHYS
$16B
$229K 0.06%
11,375
AMD icon
95
Advanced Micro Devices
AMD
$788B
$224K 0.06%
1,857
-635
-25% -$91.4K
IQLT icon
96
iShares MSCI Intl Quality Factor ETF
IQLT
$14.3B
$223K 0.06%
6,019
APOG icon
97
Apogee Enterprises
APOG
$897M
$222K 0.06%
3,102
-652
-17% -$51.2K
FBIN icon
98
Fortune Brands Innovations
FBIN
$5.83B
$219K 0.06%
3,206
MRK icon
99
Merck
MRK
$328B
$218K 0.06%
2,195
-43
-2% -$4.43K
SPGI icon
100
S&P Global
SPGI
$121B
$217K 0.06%
435
-57
-12% -$28.9K

Similar funds

Rappaport Reiches Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Rappaport Reiches Capital Management held 116 positions worth $387M, up 3% from $376M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Rappaport Reiches Capital Management deployed $12.3M of net new capital in Q4 2024, opening 3 new positions and adding to 54 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 944 shares worth $209K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $313K trimmed.

  • Rappaport Reiches Capital Management's largest Q4 2024 buy was iShares Russell 2000 ETF: 944 shares worth $209K.
  • Rappaport Reiches Capital Management added most to Vanguard Short-Term Corporate Bond ETF in Q4 2024, an estimated $7.97M increase.
  • Rappaport Reiches Capital Management's biggest Q4 2024 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $313K.
  • Rappaport Reiches Capital Management fully exited iShares Global Clean Energy ETF in Q4 2024, selling an estimated $230K.
  • Rappaport Reiches Capital Management's ten largest holdings make up 72% of its $387M portfolio in Q4 2024.
  • Rappaport Reiches Capital Management opened 3 new positions and closed 7 in Q4 2024.
  • Rappaport Reiches Capital Management's portfolio value rose 3% quarter-over-quarter to $387M.

Based on Rappaport Reiches Capital Management's 13F filing for Q4 2024, filed 21 Jan 2025.